Suppr超能文献

TLR4/MyD88表达在乳腺癌中的意义

Significance of TLR4/MyD88 expression in breast cancer.

作者信息

Chen Xiangjin, Zhao Feng, Zhang Huihao, Zhu Youzhi, Wu Kunlin, Tan Guozheng

机构信息

Department of Thyroid and Breast Surgery, First Affiliated Hospital of Fujian Medical University China.

Fujian Medical University Graduate School China.

出版信息

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7034-9. eCollection 2015.

Abstract

OBJECTIVE

To investigate the expression of TLR4/MyD88 in breast cancer, and explore the relationship between their expression and breast cancer tumor growth and invasion.

METHODS

We examined the protein expression of TLR4 and MyD88 in 60 cases of histologically confirmed breast cancer. The relationship of their protein expressions with clinical features including age at diagnosis, tumor size and stage, lymph node metastasis and distant metastasis were analyzed.

RESULTS

The IHC results showed that TLR4 and MyD88 were expressed in 63.3% (38/60) and 58.3% (35/60) of malignant breast tumors respectively. TLR4 expression in breast cancer were significantly higher than in fibroadenoma (n = 4, 20.0%) and adjacent normal tissues (n = 2, 10.0%) (P < 0.001). MyD88 expression in breast cancer were also significantly higher than in fibroadenoma (n = 4, 20.0%) and adjacent normal tissue (n = 3, 15.0%) (P < 0.001). The gene expressions of TLR4 and MyD88 were significantly higher in breast cancer than in fibroadenoma and adjacent normal tissues (P < 0.05). The protein expressions of TLR4 and MyD88 were also significantly associated with poor clinical features (P < 0.05).

CONCLUSION

TLR4 and MyD88 expression might be associated with breast cancer growth and regional and distant metastases.

摘要

目的

研究TLR4/MyD88在乳腺癌中的表达情况,并探讨其表达与乳腺癌肿瘤生长及侵袭之间的关系。

方法

我们检测了60例经组织学确诊的乳腺癌中TLR4和MyD88的蛋白表达。分析了它们的蛋白表达与包括诊断时年龄、肿瘤大小和分期、淋巴结转移及远处转移等临床特征之间的关系。

结果

免疫组化结果显示,TLR4和MyD88分别在63.3%(38/60)和58.3%(35/60)的乳腺恶性肿瘤中表达。乳腺癌中TLR4的表达显著高于纤维腺瘤(n = 4,20.0%)和癌旁正常组织(n = 2,10.0%)(P < 0.001)。乳腺癌中MyD88的表达也显著高于纤维腺瘤(n = 4,20.0%)和癌旁正常组织(n = 3,15.0%)(P < 0.001)。乳腺癌中TLR4和MyD88的基因表达显著高于纤维腺瘤和癌旁正常组织(P < 0.05)。TLR4和MyD88的蛋白表达也与不良临床特征显著相关(P < 0.05)。

结论

TLR4和MyD88的表达可能与乳腺癌的生长及局部和远处转移有关。

相似文献

1
Significance of TLR4/MyD88 expression in breast cancer.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7034-9. eCollection 2015.
2
TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.
Mol Med Rep. 2018 Sep;18(3):3411-3420. doi: 10.3892/mmr.2018.9326. Epub 2018 Jul 26.
3
Association of chemotactic factor receptor 5 gene with breast cancer.
Genet Mol Res. 2013 Nov 7;12(4):5289-300. doi: 10.4238/2013.November.7.4.
4
Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
PLoS One. 2014 Oct 31;9(10):e111639. doi: 10.1371/journal.pone.0111639. eCollection 2014.
5
Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
J Clin Pathol. 2015 Oct;68(10):795-801. doi: 10.1136/jclinpath-2015-202987. Epub 2015 Jun 4.
6
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Am J Surg Pathol. 2016 Mar;40(3):324-34. doi: 10.1097/PAS.0000000000000592.
7
Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Tumour Biol. 2016 May;37(5):6017-25. doi: 10.1007/s13277-015-4436-5. Epub 2015 Nov 23.
8
Prognostic significance of PD-L1 and PD-L2 in breast cancer.
Hum Pathol. 2016 Jan;47(1):78-84. doi: 10.1016/j.humpath.2015.09.006. Epub 2015 Sep 25.
10
Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.
J Cancer Res Clin Oncol. 2011 Aug;137(8):1245-53. doi: 10.1007/s00432-011-0998-9. Epub 2011 Jun 21.

引用本文的文献

2
Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota.
Biomedicines. 2024 Oct 23;12(11):2429. doi: 10.3390/biomedicines12112429.
5
MyD88 and Its Inhibitors in Cancer: Prospects and Challenges.
Biomolecules. 2024 May 7;14(5):562. doi: 10.3390/biom14050562.
7
Prognostic and clinicopathological significance of TLR4 expression in patients with breast cancer: a meta-analysis.
Front Oncol. 2024 Feb 23;14:1344130. doi: 10.3389/fonc.2024.1344130. eCollection 2024.
8
MyD88 signaling pathways: role in breast cancer.
Front Oncol. 2024 Jan 29;14:1336696. doi: 10.3389/fonc.2024.1336696. eCollection 2024.

本文引用的文献

1
Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast.
Tumour Biol. 2013 Apr;34(2):1053-9. doi: 10.1007/s13277-013-0645-y. Epub 2013 Jan 22.
2
Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88.
Cell Immunol. 2012;272(2):220-9. doi: 10.1016/j.cellimm.2011.10.008. Epub 2011 Oct 25.
3
Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer.
Med Oncol. 2012 Jun;29(2):486-94. doi: 10.1007/s12032-011-9885-0. Epub 2011 Mar 13.
4
Global cancer statistics.
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
9
Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells.
Eur J Clin Invest. 2009 Feb;39(2):157-64. doi: 10.1111/j.1365-2362.2008.02070.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验